Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro (Q44497225)

3 December 2017

title

Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro (English)

1 reference

3 December 2017

0 references

Jung Chung Lin

1

1 reference

3 December 2017

publication date

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

59

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

41-47

1 reference

Interferon Induction by Glycyrrhizin and Glycyrrhetinic Acid in Mice

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

The antiinflammatory activity of glycyrrhetinic acid and derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Comparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Effects of 12-O-tetradecanoyl-phorbol-13-acetate on cell proliferation and Epstein-Barr virus DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Epstein-Barr Virus: Inhibition of Replication by Three New Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Structure-activity relationship between (E)-5-(2-bromovinyl)- and 5-vinyl-1-β-d-arabinofuranosyluracil (BV-araU, V-araU) in inhibition of Epstein-Barr virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Some nucleoside analogs with anti-human immunodeficiency virus activity inhibit replication of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Replication of viral deoxyribonucleic acid and breakdown of cellular deoxyribonucleic acid in Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor alpha on infection of U-937 and MRC-5 cells by human cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Glycyrrhizic acid inhibits virus growth and inactivates virus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Therapeutic basis of glycyrrhizin on chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

Enhancement of interferon-gamma production in glycyrrhizin-treated human peripheral lymphocytes in response to concanavalin A and to surface antigen of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900030-5

7 January 2021

10.1016/S0166-3542(03)00030-5

Identifiers

DOI

1 reference

3 December 2017

1 reference